Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Femasys Inc. - Common Stock
(NQ:
FEMY
)
0.6367
+0.0605 (+10.50%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Femasys Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 06, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Friday?
↗
October 03, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 03, 2025
Via
Benzinga
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
September 25, 2025
-- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access --
From
Femasys Inc.
Via
GlobeNewswire
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
September 22, 2025
Addition strengthens FemSperm family of products and enables gynecologists to offer complete in-office sperm handling for FemaSeed Intratubal Insemination
From
Femasys Inc.
Via
GlobeNewswire
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
September 11, 2025
-- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth --
From
Femasys Inc.
Via
GlobeNewswire
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
September 08, 2025
Expands international footprint with entry into Asia-Pacific, building on recent CE Mark and UK approvals
From
Femasys Inc.
Via
GlobeNewswire
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
September 02, 2025
From
Femasys Inc.
Via
GlobeNewswire
Top stock movements in today's session.
↗
August 26, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 26, 2025
Via
Benzinga
Tuesday's session: top gainers and losers
↗
August 26, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Crude Oil Down 2%; US Durable Goods Orders Decline In July
↗
August 26, 2025
Via
Benzinga
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
August 26, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
US Stocks Mixed; American Woodmark Posts Downbeat Sales
↗
August 26, 2025
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
August 26, 2025
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 26, 2025
Via
Benzinga
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
↗
August 26, 2025
Via
Benzinga
Femasys Announces Pricing of $8.0 Million Underwritten Public Offering
August 25, 2025
From
Femasys Inc.
Via
GlobeNewswire
Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform
August 21, 2025
From
Femasys Inc.
Via
GlobeNewswire
Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
August 20, 2025
From
Femasys Inc.
Via
GlobeNewswire
Femasys Revenue Jumps 85 Percent in Q2
↗
August 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Femasys Announces Second Quarter Financial Results for 2025
August 08, 2025
From
Femasys Inc.
Via
GlobeNewswire
Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion
August 06, 2025
From
Femasys Inc.
Via
GlobeNewswire
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
July 01, 2025
From
Femasys Inc.
Via
GlobeNewswire
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
June 25, 2025
--European CE mark approval of the entire FemBloc® system marks pivotal achievement in expanding safe, accessible and non-surgical permanent contraceptive options for women--
From
Femasys Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 23, 2025
Via
Benzinga
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
June 17, 2025
From
Femasys Inc.
Via
GlobeNewswire
The Analyst Verdict: Femasys In The Eyes Of 6 Experts
↗
June 11, 2025
Via
Benzinga
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
June 11, 2025
From
Femasys Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 06, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
